| Autor: |
D, Wendt, J A, Piotrowski, B, Schönfelder, G, Marggraf, M, Thielmann, H, Jakob |
| Jazyk: |
němčina |
| Rok vydání: |
2010 |
| Předmět: |
|
| Zdroj: |
Der Urologe. Ausg. A. 49(11) |
| ISSN: |
1433-0563 |
| Popis: |
Lifelong anticoagulation, mainly with oral Vitamin K antagonists, represents the treatment of choice in patients with prosthetic heart valves to prevent thrombembolic complications. As a result, anticoagulant-related complications like excessive bleeding during interventions or surgical procedures will occur. Therefore, timely stopping of vitamin K antagonists prior to elective surgery is mandatory. However, based on the long half-life of all common vitamin K antagonists, interruption of oral anticoagulation will definitively lead to an increase of thrombembolic events. Hence, adequate bridging anticoagulation by temporary substitution of this therapy with heparin is necessary. This article gives a recommendation on the basis of the American College of Chest Physician and European Society of Cardiology current. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink